Ceribell (CBLL) Cash from Investing Activities (2023 - 2026)
Ceribell's (CBLL) quarterly Cash from Investing Activities came in at $22.4 million in Q1 2026, up 175.79% YoY from $8.1 million in Q1 2025, and down 14.05% on a QoQ basis from $26.1 million in Q4 2025.
Ceribell (CBLL) Cash from Investing Activities (2023 - 2026) Analysis & Trends
Ceribell (CBLL) has 4 years of Cash from Investing Activities data on file, last reported at $22.4 million in Q1 2026.
- Quarterly Cash from Investing Activities rose 175.79% year-over-year to $22.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$66.1 million (down 112.67% YoY) and the FY2025 annual result came in at -$118.1 million, down 7292.8% from the prior year.
- Cash from Investing Activities declined to $22.4 million in Q1 2026, from $26.1 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $26.1 million in Q4 2025 to a low of -$107.7 million in Q2 2025.
- A 4-year average of -$9.8 million and a median of -$588000.0 in 2023 frame the typical range for Cash from Investing Activities.
- The widest YoY moves for Cash from Investing Activities: up 5395.74% in 2025, down 22331.06% in 2025.
- Tracing CBLL's Cash from Investing Activities over 4 years: stood at -$683000.0 in 2023, then rose by 27.82% to -$493000.0 in 2024, then jumped by 5395.74% to $26.1 million in 2025, then retreated by 14.05% to $22.4 million in 2026.
- The last three Cash from Investing Activities figures came in at $22.4 million (Q1 2026), $26.1 million (Q4 2025), and -$6.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -639.00 Mn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | -917.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -1.96 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -193.20 Mn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 329.80 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | -115.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | -22.08 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Ceribell | 927.79 Mn | 798.53 Mn | 25.94 Mn | -606,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -606,000.00 |
| Jun 30, 2026 | -606,000.00 |
| Mar 31, 2026 | 22.44 Mn |
| Mar 31, 2026 | 22.44 Mn |
| Dec 31, 2025 | 26.11 Mn |
| Dec 31, 2025 | 26.11 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Sep 30, 2025 | -6.94 Mn |
| Jun 30, 2025 | -107.69 Mn |
| Jun 30, 2025 | -107.69 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Mar 31, 2025 | -29.61 Mn |
| Dec 31, 2024 | -493,000.00 |
| Dec 31, 2024 | -493,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -1.16 Mn |
| Jun 30, 2024 | -1.16 Mn |
| Mar 31, 2024 | -132,000.00 |
| Mar 31, 2024 | -132,000.00 |